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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of psychological interventions in comparison to usual care, no treatment, delayed provision of psychological
interventions and minimal interventions (such as screening, information provision and referral to community services such as women
shelters) for women who experience intimate partner violence (IPV).
B A C K G R O U N D
Description of the condition
Intimate partner violence (IPV) is a prevalent issue that exists
across all countries, cultures and all levels of society, with 15% to
71% of women globally reporting violence from an intimate part-
ner at some stage in their lives (Garcia-Moreno 2006; Krug 2002).
TheWorldHealthOrganization (WHO)more recently estimated
almost one third of women who have been in a relationship have
experienced physical and/or sexual violence from an intimate part-
ner (World Health Organization 2013a). The variation between
countries is thought to relate to different gender attitudes and eq-
uity across countries as well as reinforcing factors for violence such
as poverty (Elsberg 2014). An Australian study estimated a cost
of $13.6 billion in Australian dollars during 2009-2010 to the
community, mainly resulting from pain, suffering and premature
mortality (Commonwealth of Australia 2009). Domestic violence
is estimated to cost the UK £16 billion per year including costs
related to criminal justice health care, social services, housing and
losses in economic output (Walby 2009). Therefore, there are also
wider economic societal implications to be considered, in addition
to the very serious individual consequences of IPV.
This review adopts theWHO definition of IPV as “any behaviour
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within an intimate relationship that causes physical, psycholog-
ical or sexual harm to those in the relationship” (Krug 2002).
This includes acts of psychological abuse, such as intimidation and
constant belittling, and controlling behaviour such as monitoring
movements, isolation from family and friends and restricting ac-
cess to financial resources, medical care, employment and educa-
tion (Krug 2002). Compared to men, women experiencing IPV
are more likely to suffer from repeated, severe violence from their
intimate partners and are also more likely to be murdered by a
current or former intimate partner (World Health Organization
2013a). For these reasons, this review will focus on women ex-
posed to IPV, although it is acknowledged that IPV against men is
also an important issue. Future research needs to be developed for
men exposed to violence including interventions for bi-directional
violence.
Recent studies have estimated IPV as the leading cause of death,
disability and illness for women of childbearing age (Vos 2006).
Thirty-eight per cent of all murdered women (in contrast to
6% of all murdered men) are killed by intimate partners (World
Health Organization 2013a). Non-fatal injuries are also common
in women exposed to IPV. One study from theUSA estimates that
50% of all acute injuries in women result from IPV (Guth 2000).
Abused women commonly suffer with chronic health problems
(Black 2001), present very frequently to healthcare services and
require a wide range of medical services (Black 2001). The largest
physical health difference between abused and non-abusedwomen
concerns gynaecological problems, including chronic pelvic pain,
sexually-transmitted diseases and vaginal bleeding (Black 2001).
Other conditions affecting abused women include chronic pain
such as back pain and headaches, neurological symptoms such as
fainting and seizures (Black 2001; Diaz-Olavarrietta 1999), and
gastrointestinal disorders such as irritable bowel disease (Coker
2000). Further, abused women are prescribed more analgesia than
non-abused women (Lo Fo Wong 2007). IPV is also a significant
risk to pregnant women and their unborn children. The WHO
recently reported abused women to be more than twice as likely to
have an abortion, and 16% more likely to have a low birth weight
baby (World Health Organization 2013a). IPV is also associated
with increased rates of miscarriage, premature birth and foetal
injury (Pallitto 2013; Taft 2004).
The most prevalent mental health problems in women exposed to
IPV are depression, anxiety, post-traumatic stress disorder (PTSD)
and alcohol use disorders (Howard 2013; Rees 2011; Trevillion
2012; World Health Organization 2013a). Abused women are
more than twice as likely to suffer with depression compared with
non-abusedwomen (Devries 2013). Abusedwomenhave also been
found to be more likely to suffer from PTSD compared with non-
abused women (Oram 2013), and more likely to develop depen-
dency on alcohol and illicit substances (Oram 2013). Women ex-
posed to IPV often also suffer from low self-esteem and hopeless-
ness (Papadakaki 2009). These problems impact upon women’s
ability to parent their children (McCosker-Howard 2006). Given
this high prevalence of mental health problems in women exposed
to IPV, there is a potential for cognitive behavioural interventions
to improve women’s mental health.
Description of the intervention
For the purpose of this review, psychological therapy interventions
include a wide range of interventions that target cognition, moti-
vation and behaviour (see Cochrane Common Mental Disorders
(CCMD) Group’s psychological therapies list on the Cochrane
website for definitions). These include (a) formal cognitive be-
havioural therapy (CBT) and trauma-focused CBT (TF-CBT),
and CBT-based techniques; (b) third wave CBTs e.g. Acceptance
and Commitment Therapy, mindfulness; (c) integrative therapies
including motivational interviewing; and (d) behaviour therapies
e.g. Eye Movement Desensitisation Reprocessing (EMDR), and
relaxation techniques, many of which are based upon cognitive
behavioural processes (Freeman 2005). We will also include (e)
humanistic therapies e.g. supportive and non-directive therapies;
(f ) other psychologically-orientated interventions e.g. art therapy,
meditation, narrative therapy; and (g) brief psychodynamic ther-
apies. We will not including systemic therapies as this is mainly
couple-based, which is contraindicated for women experiencing
IPV by WHO guidelines (World Health Organization 2013b).
Cognitive behavioural processes (which form part of the thera-
pies listed in a-e) can also be sub-classified into three major classes
as follows (Dobson 2009): (1) cognitive re-structuring, which fo-
cuses on internal underlying beliefs and thoughts with the aim
to challenge maladaptive thought patterns; (2) coping skills ther-
apy which focuses on identification and alteration of cognitions
and behaviours that may increase the impact of negative exter-
nal events. This type of therapy is primarily used for problems
that are external to the person, focusing on reducing the conse-
quences of negative external events; (3) problem-solving therapies
which combine cognitive re-structuring and coping skills ther-
apy to change internal thought patterns and optimise responses to
external negative events. These three classes each have a slightly
different target for change, demonstrating the wide range of psy-
chological interventions based upon cognitive behavioural prin-
ciples (Dobson 2009).Other psychologically-orientated interven-
tions aim to reduce stress and promote recovery from the trauma
of the abuse.
The number of psychological intervention sessions in IPV inter-
vention trials can vary greatly, from one to 20 sessions (Hegarty
2013; Kiely 2010). Examining the mental health literature and
guidelines, low-intensity psychological interventions, for mild to
moderate mental health symptoms is recommended at an inten-
sity of at least five up to 12 sessions according to internation-
ally recognised psychological guidelines (National Collaborating
CentreMentalHealth 2005;NICE 2009).High-intensity psycho-
logical interventions, for more severe symptoms, is recommended
at an intensity of 16 to 20 sessions (NICE 2009). There is limited
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evidence from IPV trials about the recommended length of treat-
ment (WorldHealthOrganization 2013b). Similarly, there is wide
variation across interventions with regard to who delivers the psy-
chological intervention from formally trained mental healthcare
workers to social work students (Kiely 2010), to trained healthcare
workers and family doctors (Hegarty 2013).
How the intervention might work
In considering IPV interventions, it must first be recognised that
women experiencing IPV often have little to no control over their
partner’s behaviour (Hegarty 2008). Furthermore, there may be
limited insight into and labelling of the abuse. This is partic-
ularly relevant among women with poor self-esteem and social
isolation, both of which are commonly associated with abusive
relationships (Papadakaki 2009). Such individual- and relation-
ship-level circumstances contribute to the difficult process of de-
cision-making about accessing help and/or escaping the violence
(O’Doherty 2016). Furthermore, factors in a person’s community
and the wider social and cultural milieu, and intersectionality of
different factors - race, immigration status, surviving abuse add to
the complexity of a woman’s journey and need to be considered
with respect to design and delivery of services for abused women
(Chavis 2008). Therefore, decisions such as leaving an abusive re-
lationship, disclosing abusive behaviour and uptake of safety be-
haviours are much more complex than they may appear.
In this complicated setting, we consider the role of psychological
interventions and their potential for changing perceived support,
cognitions, beliefs and behaviours. We will describe how CBT-
based interventions, integrative therapies, humanistic therapies
and other psychologically-orientated interventions might impact
on a woman experiencing IPV. Firstly, cognitive behavioural inter-
ventions (e.g. formal CBT, CBT-based techniques,TF-CBT, third
wave, behavioural) are based on the proposition that behaviours
are often cognitively mediated (Butler 2006). Mental health and
social problems may be influenced by underlying cognitions and
resulting behaviours. Because cognitive activity may be monitored
and altered, behavioursmay be changed through cognitive changes
(Dobson 2009). Therefore, addressing certain thinking patterns
and beliefs may result in positive changes in symptoms, problems
and behaviours thatmay reduce some of the negative consequences
of IPV exposure (Butler 2006). It is important at this stage to
recognise that women experiencing IPV often make significant
efforts to minimise harm, and certain behaviours and cognitions
(such as safety planning) have been associatedwith harm reduction
(Tiwari 2005). These positive cognitions and behaviours provide a
good example of important potential targets for psychological in-
terventions. Further, third wave CBTs e.g. Acceptance and Com-
mittment Therapy and Mindfulness CBT act on changing the
function of psychological events and the individuals relationship
to them through acceptance, being present and committed action
(Hayes 2006). EMDR is thought to work for patients who have
been traumatised by the fact that eye movements can reduce the
intensity of disturbing thoughts, under certain conditions (Bisson
2013).
Integrative therapies e.g. motivational interviewing is one psy-
chological intervention that may be useful in assisting women.
Motivational interviewing is based on the Transtheoretical model
(Miller 2002), which identifies five stages of change with various
strategies identified to facilitate a shift from one stage to the next
(Prochaska 1992). A number of authors have however challenged
the application of the Transtheoretical model to partner abuse in-
terventions (Chang 2005; Zink 2004), as women who are abused
have minimal control over their partner’s behaviour. Therefore,
it is not immediately obvious what the target for change should
be. For example, a woman might be cognitively and emotionally
prepared to leave the relationship, but be constrained by an objec-
tive external barrier to change, and may take other actions such as
safety behaviours (Chang 2005). Cluss and colleagues have pro-
posed an alternative model, the Psychosocial Readiness Model, to
describe the process of change for victims of partner abuse (Cluss
2006). The Psychosocial Readiness Model encompasses external
as well as internal factors: awareness that the partner’s behaviour
is abuse, perceived support from others and self-efficacy/perceived
power. Self-efficacy is the ability of women to believe that they can
be successful when they take action (Benight 2004). It is a context-
specific assessment of competence to perform a specific or range
of tasks in a given domain (Bandura 1986). It has recently been
proposed that this model could have application with regards to
counselling women exposed to IPV using motivational interview-
ing (Hegarty 2008;Hegarty 2013; Saftlas 2014).Other integrative
therapies e.g. interpersonal therapy and supportive counselling in
which the therapist empathically engages the patient, helps the
patient to feel understood and assists with organising their life,
and solving life problems also has the potential to improve victim’s
mental health and ability to take action (de Mello 2005).
Thirdly, humanistic therapies e.g. supportive and non-directive
therapy may be helpful for women exposed to IPV. For women
who have decided that the abuse must end, but whose inten-
tions are not translated into action due to perceived external bar-
riers, then supportive interventions and problem-solving tech-
niques may be helpful (Mynors-Wallis 2000). Problem-solving
techniques help patients to efficiently identify problem areas, and
generate and implement solutions. Mynors-Wallis has demon-
strated the effectiveness of problem-solving therapy in a ran-
domised controlled trial for depression in primary care settings,
involving basic level psychological training of healthcare workers
(Mynors-Wallis 2000). We know that depression is common in
women exposed to IPV (World Health Organization 2013a), and
we know from qualitative studies that abused women have iden-
tified primary care clinicians as a source of assistance from whom
they would seek support (Feder 2006). Taken together, these find-
ings support the likelihood of humanistic therapies being helpful
for women exposed to IPV, delivered in an environment that is
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likely to be acceptable to these women.
Finally, other psychologically-orientated interventions e.g. art
therapy,music therapy,meditation, narrative therapymay be help-
ful conjuncts for women who have left the relationship to assist
them in managing ongoing trauma symptoms.
This background supports the findings from emerging research
as previously outlined, that psychological interventions may posi-
tively impact upon themental health and well-being of women ex-
periencing IPV (Hegarty 2013; Kiely 2010; Kubany 2004; Nelson
2012).
Why it is important to do this review
IPV is an internationally prevalent problem, with devastating, far-
reaching and long-lasting individual and societal consequences.
It is important to systematically gather and evaluate the existing
evidence about interventions that may help women exposed to
IPV.
The role of screening for IPV has been debated over recent years.
The routine screening of women for IPV in health settings, in
the absence of structured intervention, was shown in a Cochrane
review to have limited impact upon health outcomes and re-expo-
sure to violence (Taft 2013). A recent update of this review has not
markedly altered the conclusions (O’Doherty 2015). This review
did not recommend screening. However, a recent update of the
2004 review by United States Preventative Services Task Force,
which only looked at those studies relevant to the USA, does rec-
ommend IPV screening within health services (Nelson 2012).
Beyond the screening debate, researchers have examined interven-
tions that may be offered to women experiencing IPV. Recent
WHO guidelines for health professionals recommend psycholog-
ical interventions for women experiencing IPV (World Health
Organization 2013b). In particular, it points to an emerging body
of research suggesting that cognitive behavioural and motivational
interviewing interventions may have a positive impact upon the
mental health and well-being of women experiencing IPV (World
Health Organization 2013b; Saftlas 2014). Nelson and colleagues
found interventions such as counselling to reduce IPV exposure
(Nelson 2012). More recently, Hegarty and colleagues delivered a
brief counselling intervention based on motivational interviewing
techniques, delivered by family doctors within healthcare settings,
finding a reduction in depressive symptoms in women exposed
to IPV (Hegarty 2013). Saflas and colleagues also found that a
motivational interviewing intervention reduced depressive symp-
toms (Saftlas 2014). Kiely and colleagues conducted a randomised
controlled trial of an integrated cognitive behavioural intervention
delivered by psychologists and social workers, finding reduced ex-
posure to IPV during pregnancy with improved pregnancy out-
comes (Kiely 2010). Kubany and colleagues delivered a cognitive
behavioural intervention in women exposed to IPV and found a
reduction in post-traumatic stress symptoms (Kubany 2004). In
the context of this important background evidence, this review
will focus on the impact of psychological therapy interventions in
women exposed to IPV.
Advocacy in the multifaceted form of legal, housing and financial
advice, facilitated access to community resources such as shelters,
emergency housing and psychological interventions and provision
of safety planning advice or informal counselling is another in-
tervention that may be offered to women (Rivas 2015). However
evidence from a Cochrane review regarding the effect of advocacy
for women exposed to IPV has been equivocal (Rivas 2015).
Further to this, the role of CBTs for male perpetrators has been
examined in a Cochrane review, however conclusions were unable
to be drawn due to a lack of relevant randomised controlled tri-
als (Smedslund 2011). In addition, another Cochrane review ex-
amining the impact of educational and skills-based interventions
for relationship violence among adolescents and young adults also
found no impact upon episodes, attitudes or behaviours related to
relationship violence (Fellmuth 2013). Further research is there-
fore required to investigate the effectiveness of alternative inter-
ventions.
The effectiveness of cognitive behavioural interventions in the
treatment of depression, anxiety and PTSD in general populations
has been well demonstrated in recent Cochrane systematic reviews
(Bisson 2013; Butler 2006; Hunot 2007). Given the prevalence of
these specific mental health problems among women experiencing
IPV (World Health Organization 2013a), and guidance to offer
women experiencing mental health problems and IPV standard
treatment (World Health Organization 2013b), it is a reasonable
extrapolation to examine the impact of psychological interven-
tions on women experiencing IPV. Women exposed to IPV are
often referred for psychological interventions, however the impact
of these interventions remains uncertain. Before psychological in-
terventions can be recommended, it is important to evaluate the
helpfulness of these interventions in this population.
To our knowledge, the role of psychological interventions in
women exposed to IPV has never been systematically assessed to
the level of a Cochrane review (Feder 2009; Tirado-Munez 2010).
This review seeks to address this important knowledge gap and
provide practitioners and policy-makers with a further evidence
base to guide effective responses to IPV.
O B J E C T I V E S
To assess the effects of psychological interventions in comparison
to usual care, no treatment, delayed provision of psychological
interventions and minimal interventions (such as screening, in-
formation provision and referral to community services such as
women shelters) for women who experience intimate partner vio-
lence (IPV).
M E T H O D S
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Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCTs) and quasi-
RCTs. Quasi-RCTs will be included as research in this area is still
emerging. Cluster-RCTs and cross-over trials will also be eligible
for inclusion.
Types of participants
Participant characteristics
Wewill include women aged 16 years and older.Where studies in-
volve a subset of eligible participants, these studies will be included
in the review if the study includes over 50% eligible participants
who have been stratified, randomised and analysed separately.
Diagnosis
We will include women who self-report previous or current expe-
rience of IPV. This includes same-sex partners.
Co-morbidities
We will include women with co-existing mental health diagnoses
and/or substance abuse issues.
Setting
We will include women recruited via healthcare and community
settings. Healthcare settings here are taken to include general prac-
tice, antenatal and postnatal services, hospital emergency services,
gynaecology services, sexual health clinics, mental health services,
community health centres and drug and alcohol services. Com-
munity settings will include intimate partner violence organisa-
tions, justice settings and women refuge facilities.
Types of interventions
Experimental Intervention
The experimental intervention consists of psychological interven-
tions, which are taken here to include awide range of interventions
that target cognition, motivation and behaviour. These include:
1. formal cognitive behavioural therapies (CBTs) and trauma-
focused CBT (TF-CBT), and CBT-based techniques;
2. third wave CBTs e.g. Acceptance and Commitment
Therapy, mindfulness;
3. integrative therapies including motivational interviewing;
4. behaviour therapies e.g. Eye Movement Desensitisation
Reprocessing (EMDR), relaxation techniques, many of which
are based upon cognitive behavioural processes (Freeman 2005);
5. humanistic therapies e.g. supportive and non-directive
therapy; and
6. other psychologically-orientated interventions e.g. art
therapy, meditation, narrative therapy.
We will include studies where interventions involved more than
one session, where each session consists of at least 30 minutes. For
all interventions, studies of any duration or frequency of treatment
will be included, so long as treatment meets the above stated cri-
teria.
Given the lack of standardised definitions for the training require-
ments, we have not applied any restrictions to theminimum train-
ing requirements for psychological therapy delivery as this would
be an arbitrary restriction. Training for the delivery of these inter-
ventions will be liberal, and will include healthcare workers and
lay people who have received training.There is a current lack of
consensus regarding consistent minimum requirements for for-
mal psychological therapy training. Using CBT as an example, the
Beck Institute specifies important components of CBT in theCog-
nitive Therapy Scale, but does not specify the minimum training
required to achieve such competencies (Young 1980). The British
Psychological Society compiled a list of core competencies required
for CBT delivery in recognition of the disparities between health
professions with regards to CBT training, however the minimum
training to achieve these competencies similarly was not speci-
fied (Roth 2007). Rakovshik and McManus attempted to review
the effectiveness of CBT training, however they were unable to
generate definitive conclusions regarding the relationship between
CBT training and therapist competence (Rakovshik 2010). Fur-
thermore, they were also unable to find a standardised definition
of therapist competence, nor were they able to find a standardised
method to measure such competence (Rakovshik 2010).
For all interventions, mode of intervention delivery will include
face-to-face, telephone and computer-based delivery. Face-to-face
and telephone interventions will be delivered by either healthcare
workers or lay people with specific training in psychological tech-
niques. Computer-based delivery may be developed by healthcare
workers or by lay people, including intimate partner violence or-
ganisations. Both individual and group delivery of the interven-
tion will be included.
Comparator intervention
Comparator interventions will consist of usual care, no treatment,
delayed provision of psychological interventions (also referred to as
waiting-list conditions) and minimal interventions such as screen-
ing, informationprovision and referral to community services such
as women shelters.
Special circumstances
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We will include studies where psychological interventions were
delivered as an adjunct to advocacy or screening for intimate part-
ner violence (IPV), where the control group received advocacy or
screening without psychological interventions.
If we cannot assess these studies from available information, for
example subgroup analyses data, this information will be assessed
by contacting first/corresponding authors of relevant studies to
obtain potentially relevant information.
Types of outcome measures
Studies that meet the above inclusion criteria will be included
regardless of whether they report on the following outcomes.
Primary outcomes
1. Depression with outcome measures including the Center
for Epidemiologic Studies Depression Scale (CES-D) (Radloff
1977), the Patient Health Questionnaire (PHQ) (Spitzer 1999),
Beck Depression Inventory (BDI) (Beck 1961), Hospital
Anxiety and Depression Scale (HADS) (Bjelland 2002) and
Hamilton Depression Rating Scale (HAM-D) (Hamilton 1960).
2. Self-efficacy with outcome measures including the General
Self-Efficacy Scale (GSE) (Schwarzer 1995).
3. Drop-outs from treatment.
NB. Depression and self-efficacy may be positively or negatively
affected by interventions, and as such may both be regarded as
either efficacy or adverse outcomes.
Secondary outcomes
1. Mental health with outcome measures including the Short
Form 12-item survey (SF12) (Ware 1996).
2. Anxiety with outcome measures including the Patient
Health Questionnaire (PHQ) (Spitzer 1999), Generalised
Anxiety Disorder seven-item (GAD-7) (Kertz 2013; Spitzer
2006), Beck Anxiety Inventory (BAI) (Beck 1988) and Hospital
Anxiety and Depression Scale (HADS) (Bjelland 2002).
3. Post-traumatic stress disorder with outcome measures
including the PTSD checklist (PCL) (Blanchard 1996; Weathers
1991) and Short Screening Scale for DSM-IV Posttraumatic
Stress Disorder (Breslau 1999).
4. Quality of life with outcome measures including the WHO
Quality of Life scale - abbreviated version (WHOQOL-BREF)
(Skevington 2004) and EuroQol-5 dimension (EQ-5D) (Brooks
1996).
5. Re-exposure to IPV including physical, sexual and
psychological abuse with outcome measures including the
Composite Abuse Scale (CAS) (Hegarty 2005), Revised Conflict
Tactics Scale (CTS2) (Straus 1996) and Women’s Experience
with Battering (WEB) (Smith 1995).
6. Safety planning and/or safety behaviour and self-care
activities with outcome measures including the Safety Behaviour
Checklist (McFarlane 2004).
7. Use of healthcare and IPV services with outcome measures
as defined in the individual studies, since we expect these to be
study-specific as healthcare and IPV services vary greatly between
different settings and countries.
8. Social support with outcome measures including the Oslo 3
Social Support Scale (OSS3) (Dalgard 1996), Interpersonal
Support Evaluation List (ISEL) (Cohen 1983) and Inventory of
Socially Supportive Behaviours (ISSB) (Barrera 1981).
Timing of outcome assessment
We will include all time frames, however it is acknowledged that
shorter-term outcomes for re-exposure to IPV and quality of life
may not see any effect. Short-term time frames will be classified
as zero to six months, medium-term time frames will be classified
as greater than six months to 12 months, and long-term time will
be classified as periods greater than 12 months. The primary time
frame will be medium-term time frames.
Hierarchy of outcome measures
In the case thatmore than one outcomemeasure is used tomeasure
single outcomes in the included studies, in selecting a set of data
for inclusion in meta-analysis, we will give preference to outcome
measures according to the order in which they are listed above.
Search methods for identification of studies
The Cochrane, Common Mental Disorders
Controlled Trials Register (CCMDCTR)
The Cochrane Common Mental Disorders Group (CCMD)
maintain two clinical trials registers at their editorial base in York,
UK, a references register and a studies-based register. The CCD-
MDCTR-References Register contains over 40,000 reports of ran-
domised controlled treatment trials for common mental disorders
(depression, anxiety, eating disorders, self-harm). Approximately
50% of these reports have been tagged to individual, coded tri-
als. The coded trials are held in the CCMDCTR-Studies Register
and records are linked between the two registers through the use
of unique study ID tags. Coding of trials is based on the EU-Psi
coding manual.
Reports of trials for inclusion in the Group’s registers are col-
lated from routine, generic searches of MEDLINE (1950-), Em-
base (1974-) and PsycINFO (1967-); quarterly searches of the
Cochrane Central Register of Controlled Trials (CENTRAL) and
review specific searches of additional databases. Reports of trials
are also sourced from international trials registers c/o the World
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Health Organization’s trials portal (ICTRP), ClinicalTrials.gov,
drug companies, the handsearching of key journals, conference
proceedings and other (non-Cochrane) systematic reviews and
meta-analyses.
Details of CCMD’s core search strategies (used to identify RCTs)
can be found on the Group’s website with an example of the core
MEDLINE search displayed in Appendix 1.
Electronic searches
We will search the group’s specialised register, the CCMDCTR
using the following strategies.
1. CCMDCTR-Studies Register
We will search the studies register using controlled vocabulary
terms.
Comorbid healthcare condition = (domestic violence or rape or sex-
ual abuse or spousal abuse)
2. CCMDCTR-References Register
We will search the references register using a more sensitive set of
free-text terms to identify additional untagged/uncoded reports of
RCTs:
Free-text = (((home* or domestic* or spous* or partner* or women or
woman or mother*) NEAR (abus* or violen*)) or “battered women”
or (violen* NEAR (date or dating)) or rape or ((sex* NEAR abuse*)
not child*:ti))
3. We will conduct complementary searches on the following bib-
liographic databases using relevant subject headings (controlled
vocabularies) and search syntax, appropriate to each resource:
1. Ovid MEDLINE (1950 to present) - search strategy listed
in Appendix 2
2. Ovid Embase (1980 to present)
3. Ebsco CINAHL (1982 to present)
4. Ovid PsycINFO (1806 to present)
5. Cochrane Central Register of Controlled Trials
(CENTRAL) (all years)
6. Database of Abstracts of Reviews for Effectiveness (DARE)
(all years)
7. Web of Science Social Science Citation Index (1900 to
present)
8. Proquest Published International Literature on Traumatic
Stress (PILOTS) (1871 to present)
We will apply no restrictions on date, language or publication
status to the searches.
4. We will search the international trial registries via the World
HealthOrganization’s trials portal (ICTRP) and ClinicalTrials.gov
to identify unpublished or ongoing studies.
Searching other resources
Grey literature
We will search sources of grey literature including dissertations
and theses, clinical guidelines and reports from regulatory agencies
in a non-systematic manner (where appropriate) including:
1. World Health Organization;
2. Domestic Violence Data Sources.
Reference lists
Wewill check the reference lists of all included studies and relevant
systematic reviews to identify additional studies missed from the
original electronic searches (for example, unpublished or in-press
citations). We will also conduct a forward citation search on the
Web of Science.
Correspondence
We will contact trialists and subject experts for information on
unpublished or ongoing studies or to request additional trial data.
Data collection and analysis
Selection of studies
Two review authors (MT and JT) will independently assess the ti-
tles and abstracts of articles identified through the literature search
against the inclusion criteria. Abstracts will be coded as ’retrieve’
(eligible or potentially eligible or unclear) or ’do not retrieve’. In
the event of disagreements about abstract inclusion, the full arti-
cle will be assessed by both review authors and then discussed. If
agreement cannot be reached by discussion, a third review author
(LOD) will be consulted as mediator. Final decisions will be made
by consensus.
Full-text articles for selected abstracts will then be retrieved, and
each article will be assessed independently against the inclusion
criteria by two review authors (MT and LOD). Studies will either
be identified for inclusion, or identified for exclusion. We will
contact study authors as required, to decide whether the inclusion
criteria are met. We will record reasons for excluding ineligible
studies. As with earlier stages of the study selection process, in the
event of disagreements that cannot be resolved by discussion, a
third author (KH) will be consulted as mediator. Final decisions
will be made by consensus.
We will identify and exclude duplicate records and we will collate
multiple reports that relate to the same study so that each study
rather than each report is the unit of interest in the review.
Wewill record the selection process in sufficient detail to complete
a PRISMA flow diagram (Moher 2009) and ’Characteristics of
excluded studies’ table.
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Data extraction and management
We will use a data collection form to extract study characteristics
and outcome data which has been piloted on at least one study
in the review. Two pairs of review authors (MT and LOD, GG
and JT) will extract study characteristics and outcome data from
included studies.
We will extract the following study characteristics.
1. Methods: brief description of study design and
randomisation method, total duration of study and date and
location of study.
2. Participants: total number of participants, baseline
characteristics including gender and age range, study setting,
study’s inclusion criteria and exclusion criteria, number of
eligible people recruited and assigned, numbers dropped out and
numbers analysed.
3. Interventions: number of intervention groups, type of
psychological intervention, mode of delivery, frequency and
duration of delivery, level of mental health training of person
delivering the intervention and the relevant comparator
intervention characteristics.
4. Outcomes: primary and secondary outcomes, outcome
measures used and timing of outcome measurement.
5. Notes: funding for trial, and notable conflicts of interest of
trial authors.
We will note in the ’Characteristics of included studies’ table if
outcome data were not reported in a usable way. We will resolve
disagreements by consensus or by involving amediator (KH). One
review author (JT) will transfer data into the Review Manager
(Revman 2014) file. We will double-check that data are entered
correctly by comparing the data presented in the systematic review
with the study reports. A second review author (KH) will spot-
check study characteristics for accuracy against the trial report.
Main comparisons
Psychological interventions versus usual care/waiting list/minimal
interventions.
We will stratify the results by type of therapy (categories 1-6 in
Types of interventions) should data allow.
Assessment of risk of bias in included studies
Individually-randomised trials
Two pairs of review authors (MT and LOD, GG and JT) will
independently assess risk of bias for each included study using the
criteria outlined in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011a). Each review author will rate the
included studies for each of the domains listed below with ratings
of ‘high risk of bias’, ‘low risk of bias’ or ‘unclear risk of bias’ and
provide the reason supporting their judgement.Wewill resolve any
disagreements by contacting the study author as required, then by
discussion. In the event of disagreements that cannot be resolved
by discussion, a third review author (KH) will be consulted as
mediator.
For individually-randomised trials, we will address the following
domains to assess risk of bias.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other bias - consistent with our associated reviews on
advocacy and screening in IPV (Rivas 2015; Taft 2013), we will
also assess for protection against contamination (whether
measures were taken to prevent or minimise the possibility that
women in the control arm might receive part, or all of the
intervention, were described sufficiently to allow assessment of
possible contamination between groups).
We will also assess the following.
1. Therapist qualifications.
2. Treatment fidelity (whether the therapy was measured
against a manual or scale).
3. Researcher allegiance/conflict of interest (whether the
researcher has a vested interest in the provided therapies).
4. Therapist allegiance/conflict of interest (whether the
therapist has a vested interest in the provided therapies).
We will summarise the ’Risk of bias’ judgements across different
studies for each of the domains listed. We will consider blind-
ing separately for different key outcomes where necessary (e.g. for
unblinded outcome assessment, risk of bias for all-cause mortal-
ity may be very different than for a patient-reported pain scale).
Where information on risk of bias relates to unpublished data or
correspondence with a trialist, we will note this in the ’Risk of bias’
table.
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
Cluster-randomised trials
We will assess the risk of bias for cluster-randomised trials as out-
lined above for individually-randomised trials. In addition, we will
address the following domains specific to cluster-randomised trials
in accordance with Section 16.3.2 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011b).
1. Identification and recruitment bias.
2. Baseline imbalance between randomised groups.
3. Loss of clusters.
4. Analysis does not use appropriate analytical methods that
take into account the clustering.
5. Assess the possible differences between the intervention
effects estimated with cluster- and/or individually-randomised
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trials, for example contamination in individually-randomised
trials, different randomisation units (such as, general practice
versus community) and sample size of clusters in cluster-
randomised trials.
Cross-over trials
We will first assess cross-over trials for their suitability in evaluat-
ing the psychological therapy intervention in women experiencing
intimate partner abuse using the criteria described Section 16.4.2
of the Cochrane Handbook for Systematic Reviews of intervention.
If the design is appropriate, in addition to the criteria outlined
for individual-randomised trials and cluster-randomised trials (if
the unit of allocation is a cluster e.g. stepped wedge cluster-ran-
domised trial), we will address domains specific to cross-over trials
as outlined in Section 16.4.3 of the Cochrane Handbook for Sys-
tematic Reviews of intervention (Higgins 2011b):
1. whether there is a carry-over treatment effect from one
period to the next;
2. whether only first period data are available;
3. incorrect analysis is performed;
4. comparability of results with those from parallel-group
trials;
5. drop-out of participants after the first treatment;
6. number of treatments or periods used unclear.
Measures of treatment effect
Dichotomous data
Counts and percentages by trial arm are required for each study
that reports dichotomous outcomes. Using the summary data, we
will calculate the pooled odds ratio (OR) and 95% confidence in-
terval (CI) across the trials for each outcome. In studies where data
required to calculate the OR are neither available nor obtainable
from study authors, we will provide the findings as published by
the study authors.
Continuous data
Means and standard deviations by trial arm are required for studies
that report continuous outcomes. We will calculate the mean dif-
ference (MD) when the pooled trials use the same scale to measure
the outcome of interest. We will calculate the standardised mean
difference (SMD), where the absolute mean difference is divided
by the pooled standard deviation, when the outcome is measured
using different measurement scales. Data will be presented as a
scale with a consistent direction of effect. Where means and stan-
dard deviations are not available or obtainable from the authors,
we will provide the findings as published by the study authors.
Continuous outcome data that do not have a normal distribution
and are reported as medians and interquartile ranges in the papers
will be described in the review using a narrative approach.
Unit of analysis issues
Cluster-randomised trials
Statistical methods for cluster-randomised trials that allow for the
effect of clustering are described in Section 16.3.3 of the Cochrane
Handbook for Systematic Reviews (Higgins 2011b). If studies have
not accounted for the effects of clustering in the analysis, we will
use an approximate analyses as described in Section 16.3.6 of the
CochraneHandbook for Systematic Reviews (Higgins 2011b), which
in addition to summary measures nominated for continuous and
binary outcomes above, requires an estimate of the intra-class cor-
relation coefficient of the outcome (ICC) and average cluster size.
The ICC quantifies the proportion of the total variability of the
outcome attributable to the variability between clusters (Donner
2000). When available, we will extract estimates of the ICC di-
rectly from the published papers. If not reported, we will contact
the study authors in an attempt to obtain such data; otherwise we
will obtain estimates of the ICC from external sources. We will
conduct a sensitivity analysis using a range of plausible values for
the ICC when the estimates of ICC have not been obtained from
the trial data.
Cross-over trials
Statistical methods described in Sections 16.4.5 and 16.4.6 of the
Cochrane Handbook for Systematic Reviews of intervention (Higgins
2011b) will be used to incorporate cross-over trials into the meta-
analysis. We will conduct sensitivity analyses when missing data,
such as the standard error of the estimated treatment effect or
within-individual correlation coefficient, have been imputed for
themeta-analyses. For cross-over trials where the unit of allocation
is the cluster, we will use appropriate statistical methods, as out-
lined for cluster-randomised trials, to account for the clustering
in the data. For the meta-analysis, we will analyse parallel group
and cross-over trials separately and combine them (Section 16.4.7
of the Cochrane Handbook for Systematic Reviews of intervention
(Higgins 2011b)).
Studies with multiple treatment groups
Where multiple trial arms are reported in a single trial, we will
include only the relevant arms. Statistical methods for studies with
multiple intervention groups to be used in this review are described
in Section 16.5.4 of theCochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011b). We will examine studies to see
whether they have accounted for the effects of multiple interven-
tions in their trials. If meta-analysis is able to be conducted, we
9Psychological therapies for women who experience intimate partner violence (Protocol)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
will combine all relevant control groups into a single group, and
combine all relevant intervention groups into a single group.
Dealing with missing data
We will contact study authors in an attempt to verify key study
characteristics and obtain missing numerical outcome data where
possible.Wewill document all correspondence with study authors,
and we will report which study authors responded in the full re-
view.
It will not be possible to use analytical methods that handlemissing
data because only summary data will be collected from the studies
and individual level data will not be sourced from the authors
(Egger 2001). We will address the potential impact of missing
outcome data in the assessment of risk of bias described earlier.
If appropriate, a sensitivity analysis will be performed to assess
the impact of the missing information about the studies on the
results of the systematic review as described in Sections 16.2.2
(dichotomous outcomes) and16.2.3 (continuous outcomes) of the
CochraneHandbook for Systematic Reviews of Interventions (Higgins
2011b).
Assessment of heterogeneity
Consistency of the results across studies will be assessed using
graphical representations (Egger 1997) and will be quantified us-
ing the I2 statistic (Deeks 2017), which measures the proportion
of variation of the estimated treatment effect attributable to het-
erogeneity across studies included in the meta-analysis rather than
sampling error. The observed value of I2 will be interpreted using
the guide given in Chapter 9.5.2 of the Cochrane Handbook for
Systematic Reviews of Interventions (Deeks 2017) and taking into
consideration the size and direction of effects and the strength of
evidence for heterogeneity using the P value from the Chi2 test
and the 95% confidence interval for I2. As outlined in Cochrane
Handbook for Systematic Reviews of Interventions (Deeks 2017), a
rough guide to interpretation of I2 is as follows: 0% to 40% might
not be important; 30% to 60% may represent moderate hetero-
geneity; 50% to 90% may represent substantial heterogeneity and
75% to 100% represents considerable heterogeneity. Where there
is evidence for statistical heterogeneity, strategies as outlined in
Chapter 9.5.3 of the Cochrane Handbook for Systematic Reviews of
Interventions (Deeks 2017) will be employed to identify poten-
tial sources of heterogeneity among the results of the studies. In
particular, differences in the characteristics of the studies or other
factors will be explored as possible explanations for heterogeneity
in the results. Any differences identified will be summarised in the
narrative summary.
Assessment of reporting biases
Wewill construct funnel plots if there are more than 10 studies, to
investigate any association between effect size and study precision
(which is closely related to sample size) (Egger 1997). Such an
association could be due to publication or related biases, or due
to systematic differences between small and large studies. If an
association is identified, clinical diversity of the studies will be
further examined as a possible explanation. If appropriate, we will
also conduct sensitivity analysis to determine whether assumptions
about the effect of the bias would impact the estimated treatment
effect and the conclusions of the review.
Data synthesis
We will perform a meta-analysis if there are sufficient data and it
is meaningful to pool the data across the studies, for instance if
the treatments, participants and the underlying clinical question
are similar enough for pooling to make sense.
The decision whether to performmeta-analysis will be determined
by the comparability of populations, denominators and interven-
tions (clinical heterogeneity), the comparability of the duration
of follow-up (methodological heterogeneity) and comparability of
outcomes. A random-effects model will be used to analyse the data
across the studies. If it is inappropriate to combine the data in a
meta-analysis, the effect sizes with 95% CIs or standard errors of
individual studies will be reported and summarised using a narra-
tive approach.
Subgroup analysis and investigation of heterogeneity
We are aware of the limitations of subgroup analyses, however we
remain interested in the following topics in relation to our primary
outcomes. If sufficient numbers of studies are identified, we will
perform subgroup analyses for the following.
1. Recruitment setting of participants: healthcare setting,
community setting, shelter setting.
2. Type of intervention: CBT (including TF-CBT).
3. Intensity of intervention: two to five sessions, five or more
sessions.
4. Person delivering the intervention: healthcare workers, non
healthcare workers.
Recruitment setting has been identified for subgroup analysis as
there may be differences in severity of IPV exposure between
women recruited via health care as opposed to community set-
tings or shelter settings. Recruitment setting may also influence
the level of receptiveness to psychological intervention. Subgroup
analyses regarding the type and intensity of interventions, as well
as the background of the person delivering the intervention, have
important practical implications for our review findings and rec-
ommendations.
We will use a simple approach described in Chapter 9.6.3 of the
Cochrane Handbook for Systematic Reviews of Interventions (Deeks
2017) to investigate whether there is a difference in the interven-
tion effect between the subgroups. If there is a sufficient number
of studies in the meta-analysis (at least 10), meta-regression tech-
niques as described in Chapter 9.5.4 of the Cochrane Handbook
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for Systematic Reviews of Interventions (Deeks 2017) will be used
instead.
If a large degree of heterogeneity is identified, we will first check
data for errors. If data are correct, we will conduct a sensitivity
analysis by excluding certain studies from the existing meta-anal-
ysis to assess the influence of the studies on the degree of hetero-
geneity.
Sensitivity analysis
Primary analyses will be based on available data from all included
studies relevant to the comparison of interest. We will perform
sensitivity analyses to determine whether conclusions are robust
to decisions made during the review process, such as quality of
data, the inclusion/exclusion of studies from meta-analysis or ap-
proaches to analyses. These sensitivity analyses may include the
following.
1. Study quality - allocation concealment will be used as a
measure of study quality. If studies are rated ‘low’ risk of bias for
allocation concealment then they are high quality; if ‘unclear’ or
‘high’ they are rated as low quality.
2. Differential dropout - we will exclude trials where dropouts
are replaced without randomisation.
3. Impact of missing outcome data - we will exclude trials
where missing data have been imputed.
Additional sensitivity analyses may be required if particular issues
related to the studies under review arise.
’Summary of findings’ table
We will prepare ’Summary of findings’ tables to summarise key
findings of this review.Wewill select up to sevenof themost impor-
tant outcomes (including adverse outcomes) and present standard-
ised effect size estimates and95%CIs, using theGRADEapproach
to assess the quality of the body evidence. We will use GRADEpro
to create our ’Summary of findings’ tables (GRADEpro 2008) and
follow standard methods as described in the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011a) to prepare
our ’Summary of findings’ table. The following seven important
outcomes (measured in the medium term) that will be included.
1. Depression with outcome measures including the Center
for Epidemiologic Studies Depression Scale (CES-D) (Radloff
1977), the Patient Health Questionnaire (PHQ) (Spitzer 1999),
Beck Depression Inventory (BDI) (Beck 1961), Hospital
Anxiety and Depression Scale (HADS) (Bjelland 2002) and
Hamilton Depression Rating Scale (HAM-D) (Hamilton 1960).
2. Self-efficacy with outcome measures including the General
Self-Efficacy Scale (GSE) (Schwarzer 1995).
3. Dropouts from treatment.
4. Anxiety with outcome measures including the Patient
Health Questionnaire (PHQ) (Spitzer 1999), Generalised
Anxiety Disorder seven-item (GAD-7) (Kertz 2013, Spitzer
2006), Beck Anxiety Inventory (BAI) (Beck 1988) and Hospital
Anxiety and Depression Scale (HADS) (Bjelland 2002).
5. Post-traumatic stress disorder with outcome measures
including the PTSD checklist (PCL) (Blanchard 1996, Weathers
1991) and Short Screening Scale for DSM-IV Posttraumatic
Stress Disorder (Breslau 1999).
6. Quality of life with outcome measures including the WHO
Quality of Life scale - abbreviated version (WHOQOL-BREF)
(Skevington 2004) and EuroQol-5 dimension (EQ-5D) (Brooks
1996).
7. Re-exposure to IPV including physical, sexual and
psychological abuse with outcome measures including the
Composite Abuse Scale (CAS) (Hegarty 2005), Revised Conflict
Tactics Scale (CTS2) (Straus 1996) and Women’s Experience
with Battering (WEB) (Smith 1995).
’Summary of findings’ tables will be created after we have entered
data into RevMan (Revman 2014), written up our results and
conducted the ’Risk of bias’ assessment. However, the ’Summary
of findings’ table will be created before writing our discussion,
abstract and conclusions, to allow the opportunity to consider
the impact of the risk of bias in the studies contributing to each
outcome upon the mean treatment effect and our confidence in
these findings.
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A P P E N D I C E S
Appendix 1. CCMD-CTR core MEDLINE search
CCMD’s core search strategy used to inform the Group’s specialised register: OVID Medline
A search alert based on condition + RCT filter only
1. [MeSH Headings]:
eating disorders/ or anorexia nervosa/ or binge-eating disorder/ or bulimia nervosa/ or female athlete triad syndrome/ or pica/ or
hyperphagia/ or bulimia/ or self-injurious behavior/ or self mutilation/ or suicide/ or suicidal ideation/ or suicide, attempted/ or
mood disorders/ or affective disorders, psychotic/ or bipolar disorder/ or cyclothymic disorder/ or depressive disorder/ or depression,
postpartum/ or depressive disorder, major/ or depressive disorder, treatment-resistant/ or dysthymic disorder/ or seasonal affective
disorder/ or neurotic disorders/ or depression/ or adjustment disorders/ or exp antidepressive agents/ or anxiety disorders/ or agoraphobia/
or neurocirculatory asthenia/ or obsessive-compulsive disorder/ or obsessive hoarding/ or panic disorder/ or phobic disorders/ or stress
disorders, traumatic/ or combat disorders/ or stress disorders, post-traumatic/ or stress disorders, traumatic, acute/ or anxiety/ or anxiety,
castration/ or koro/ or anxiety, separation/ or panic/ or exp anti-anxiety agents/ or somatoform disorders/ or body dysmorphic disorders/
or conversion disorder/ or hypochondriasis/ or neurasthenia/ or hysteria/ ormunchausen syndrome by proxy/ ormunchausen syndrome/
or fatigue syndrome, chronic/ or obsessive behavior/ or compulsive behavior/ or behavior, addictive/ or impulse control disorders/
or firesetting behavior/ or gambling/ or trichotillomania/ or stress, psychological/ or burnout, professional/ or sexual dysfunctions,
psychological/ or vaginismus/ or Anhedonia/ or Affective Symptoms/ or *Mental Disorders/
2. [Title/ Author Keywords]:
(eating disorder* or anorexia nervosa or bulimi* or binge eat* or (self adj (injur* or mutilat*)) or suicide* or suicidal or parasuicid* or
mood disorder* or affective disorder* or bipolar i or bipolar ii or (bipolar and (affective or disorder*)) or mania or manic or cyclothymic*
or depression or depressive or dysthymi* or neurotic or neurosis or adjustment disorder* or antidepress* or anxiety disorder* or
agoraphobia or obsess* or compulsi* or panic or phobi* or ptsd or posttrauma* or post trauma* or combat or somatoform or somati#
ation or medical* unexplained or body dysmorphi* or conversion disorder or hypochondria* or neurastheni* or hysteria or munchausen
or chronic fatigue* or gambling or trichotillomania or vaginismus or anhedoni* or affective symptoms or mental disorder* or mental
health).ti,kf.
3. [RCT filter]:
(controlled clinical trial.pt. or randomized controlled trial.pt. or (randomi#ed or randomi#ation).ab,ti. or randomly.ab. or (random*
adj3 (administ* or allocat* or assign* or class* or control* or determine* or divide* or distribut* or expose* or fashion or number* or
place* or recruit* or subsitut* or treat*)).ab. or placebo*.ab,ti. or drug therapy.fs. or trial.ab,ti. or groups.ab. or (control* adj3 (trial* or
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study or studies)).ab,ti. or ((singl* or doubl* or tripl* or trebl*) adj3 (blind* or mask* or dummy*)).mp. or clinical trial, phase ii/ or
clinical trial, phase iii/ or clinical trial, phase iv/ or randomized controlled trial/ or pragmatic clinical trial/ or (quasi adj (experimental
or random*)).ti,ab. or ((waitlist* or wait* list* or treatment as usual or TAU) adj3 (control or group)).ab.)
4. (1 and 2 and 3)
Records are screened for reports of RCTs within the scope of the Cochrane Common Mental Disorders Group. Secondary reports of
RCTs are tagged to the appropriate study record.
Similar search alerts are also conducted on OVID EMBASE and PsycINFO, using relevant subject headings (controlled vocabularies)
and search syntax, appropriate to each resource.
Appendix 2. MEDLINE search strategy
OVID MEDLINE will be searched using the following terms (1950 to present):
1. BATTERED WOMEN/
2. DOMESTIC VIOLENCE/
3. SPOUSE ABUSE/
4. (abuse$ adj3 wom#n).tw.
5. (abuse$ adj3 spous$).tw.
6. (abuse$ adj3 partner$).tw.
7. ((wife or wives) adj3 abuse$).tw.
8. ((wife or wives or wom#n) adj3 batter$).tw.
9. (partner$ adj3 violen$).tw.
10. (spous$ adj3 violen$).tw.
11. ((domestic* or home*) adj3 violen*).tw.
12. ((domestic* or home*) adj3 abuse*).tw.
13. (violen* adj3 (date or dating)).tw.
14. (date adj3 rape).tw.
15. (dating adj3 violen$).tw.
16. (acquaintance adj3 (rape or violen$)).tw.
17. ((relation* or interperson*) adj3 (abuse$ or violen$)).tw.
18. stalk*.tw.
19. ((domestic or marital or partner*1 or spous*) adj3 (rape or (sex* adj1 (abuse* or assault*)))).mp.
20. ((abuse* or violen*) adj3 (marital or marriage)).tw.
21. or/1-20
22. PSYCHOTHERAPY/ or PSYCHOTHERAPY, GROUP/
23. (psychotherapy or (psychological adj (therap* or intervention))).tw.
24. COGNITIVE THERAPY/
25. ((cogniti$ adj3 behavio$) or CBT).tw.
26. (cognitive resructur* or cognitive processing).tw.
27. (metacognitive or meta-cognitive).tw.
28. CBASP.tw.
29. BEHAVIOR THERAPY/
30. (behavio* adj3 (therap* or psychotherap* or intervention* or program* or training)).tw.
31. (behavio* activat*).tw.
32. (psychobehavio* or psycho-behavio*).tw.
33. COUNSELING/
34. counsel*.tw.
35. MOTIVATIONAL INTERVIEWING/
36. MOTIVATION/
37. (motivational adj3 (interview* or intervention* or therap* or psychotherap* or program* or training)).tw.
38. NONDIRECTIVE THERAPY/
39. (non-directive or nondirective).tw.
40. (analytic and (cogniti* or therap* or psychotherapy*)).tw.
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41. (acceptance adj2 commitment).tw.
42. (compass* foc*).tw.
43. (dialectic* or DBT).tw.
44. diffusion.tw.
45. (mind train*).tw.
46. (mindful* or meditation or relaxation).tw.
47. (problem sol*).tw.
48. (rational emotive).tw.
49. (reality adj (therap* or psychotherap*)).tw.
50. BATTERED WOMEN/th or DOMESTIC VIOLENCE/pc or VIOLENCE/pc or SPOUSE ABUSE/th,pc
51. or/22-50
52. randomized controlled trial.pt.
53. controlled clinical trial.pt.
54. randomi#ed.ti,ab.
55. randomly.ab.
56. placebo.ab.
57. trial.ti,ab.
58. groups.ab.
59. (control$ adj3 (trial or study)).ab,ti.
60. ((singl$ or doubl$ or tripl$ or trebl$) adj3 (blind$ or mask$ or dummy)).mp.
61. ((waitlist* or (wait* adj2 list*)) and (control* or group)).ab.
62. ((usual care or care as usual) and (control* or group)).ab.
63. (treatment as usual or TAU).ab.
64. or/52-63
65. (21 and 51 and 64)
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